4.7 Article

Initial cognitive decline is associated with cortical thinning in early Parkinson disease

Journal

NEUROLOGY
Volume 82, Issue 22, Pages 2017-2025

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000000483

Keywords

-

Funding

  1. Michael J. Fox Foundation for Parkinson's Research
  2. Abbott
  3. Avid Radiopharmaceuticals
  4. Biogen Idec
  5. Bristol-Myers Squibb
  6. Covance
  7. Elan
  8. GE Healthcare
  9. Genentech
  10. GSK-GlaxoSmithKline
  11. Lilly
  12. Merck
  13. MSD-Meso Scale Discovery
  14. Pfizer
  15. Roche
  16. UCB
  17. Marie Curie fellowship for postdoctoral researchers [FP7-PEOPLE-2012-IEF-328758]

Ask authors/readers for more resources

Objectives: Our aim was to assess cortical thickness in a large multicenter cohort of drug-naive patients with early Parkinson disease (PD), with and without mild cognitive impairment (MCI), and explore the cognitive correlates of regional cortical thinning. Methods: One hundred twenty-three newly diagnosed patients with PD and 56 healthy controls with 3-tesla structural MRI scans and complete neuropsychological assessment from the Parkinson's Progression Markers Initiative were included. Modified Movement Disorders Society Task Force level II criteria were applied to diagnose MCI in PD. FreeSurfer image processing and analysis software was used to measure cortical thickness across groups and the association with cognitive domains and tests. Results: In patients with MCI, atrophy was found in temporal, parietal, frontal, and occipital areas compared with controls. Specific regional thinning in the right inferior temporal cortex was also found in cognitively normal patients. Memory, executive, and visuospatial performance was associated with temporoparietal and superior frontal thinning, suggesting a relationship between cognitive impairment and both anterior and posterior cortical atrophy in the whole patient sample. Conclusions: These findings confirm that MCI is associated with widespread cortical atrophy. In addition, they suggest that regional cortical thinning is already present at the time of diagnosis in patients with early, untreated PD who do not meet the criteria for MCI. Together, the results indicate that cortical thinning can serve as a marker for initial cognitive decline in early PD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available